Influence of the BRAF V600E mutation on expression of vascular endothelial growth factor in papillary thyroid cancer
YS Jo, S Li, JH Song, KH Kwon, JC Lee… - The Journal of …, 2006 - academic.oup.com
Context: The BRAF mutation may influence the expression patterns of molecular markers
that are related to the development and progression of thyroid cancer. Objective: The …
that are related to the development and progression of thyroid cancer. Objective: The …
Clinical significance of BRAF (V600E) mutation and Ki-67 labeling index in papillary thyroid carcinomas
H Nakayama, A Yoshida, Y Nakamura… - Anticancer …, 2007 - ar.iiarjournals.org
Background: Activating mutations of the BRAF gene have recently been reported in thyroid
carcinomas. In particular, V600E mutation is highly prevalent in papillary thyroid carcinoma …
carcinomas. In particular, V600E mutation is highly prevalent in papillary thyroid carcinoma …
[PDF][PDF] The relation between BRAFV600E mutation and clinicopathological characteristics of papillary thyroid cancer
Aim BRAF mutation inhibits many tumour suppressor genes, increases pro-angiogenic
molecules and reduces radioactive iodine uptake of tumour in papillary thyroid cancer …
molecules and reduces radioactive iodine uptake of tumour in papillary thyroid cancer …
Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma
C Lupi, R Giannini, C Ugolini, A Proietti… - The Journal of …, 2007 - academic.oup.com
Context: Because very few studies have examined the correlation between BRAF mutations
and clinicopathological features of papillary thyroid carcinoma (PTC), we analyzed here a …
and clinicopathological features of papillary thyroid carcinoma (PTC), we analyzed here a …
Higher rate of BRAF mutation in papillary thyroid cancer over time A single‐institution study
A Mathur, W Moses, R Rahbari, E Khanafshar… - Cancer, 2011 - Wiley Online Library
BACKGROUND: The incidence of thyroid cancer has doubled over the past decade. The
reason for this dramatic increase in incidence is controversial. Some investigators have …
reason for this dramatic increase in incidence is controversial. Some investigators have …
BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer
M Xing, WH Westra, RP Tufano, Y Cohen… - The Journal of …, 2005 - academic.oup.com
Context: Use of BRAF mutation in papillary thyroid cancer (PTC) has the potential to improve
risk stratification of this cancer. Objective: The objective of the study was to investigate the …
risk stratification of this cancer. Objective: The objective of the study was to investigate the …
BRAFV600E mutation in Turkish patients with papillary thyroid cancer: strong correlation with indicators of tumor aggressiveness
N Kurtulmus, M Duren, U Ince, M Cengiz Yakicier… - Endocrine, 2012 - Springer
Papillary thyroid cancer (PTC) constitutes more than 90% of the thyroid cancers. MAP
kinase/ERK pathway plays an important role in the development of several cancers. BRAF …
kinase/ERK pathway plays an important role in the development of several cancers. BRAF …
BRAFV600E Mutation and Outcome of Patients with Papillary Thyroid Carcinoma: A 15-Year Median Follow-Up Study
R Elisei, C Ugolini, D Viola, C Lupi… - The Journal of …, 2008 - academic.oup.com
Background: The BRAFV600E mutation is the most frequent genetic alteration in papillary
thyroid carcinoma (PTC). The role of BRAFV600E mutation as a poor prognostic factor has …
thyroid carcinoma (PTC). The role of BRAFV600E mutation as a poor prognostic factor has …
Allele Percentage of the BRAF V600E Mutation in Papillary Thyroid Carcinomas and Corresponding Lymph Node Metastases: No Evidence for a Role in Tumor …
G Gandolfi, V Sancisi, F Torricelli… - The Journal of …, 2013 - academic.oup.com
Context: The relevance of the BRAF V600E mutation in papillary thyroid carcinoma (PTC) as
a negative prognostic factor is a subject of intense debate. This mutation has been …
a negative prognostic factor is a subject of intense debate. This mutation has been …
The prevalence and prognostic value of BRAF mutation in thyroid cancer
E Kebebew, J Weng, J Bauer, G Ranvier… - Annals of …, 2007 - journals.lww.com
Objective: To examine the prevalence of BRAF mutation among thyroid cancer histologic
subtypes and determine the association of BRAF mutation with indicators of poor prognosis …
subtypes and determine the association of BRAF mutation with indicators of poor prognosis …
相关搜索
- braf v600e mutation
- growth factor thyroid cancer
- brafv600e mutation thyroid cancer
- tumor aggressiveness thyroid cancer
- higher rate thyroid cancer
- turkish patients thyroid cancer
- clinicopathologic implications thyroid cancer
- strong correlation thyroid cancer
- subgroup analysis thyroid cancer
- clinicopathological characteristics thyroid cancer
- prognostic value thyroid cancer
- papillary thyroid carcinomas
- tumor progression thyroid carcinomas
- brafv600e mutation outcome of patients
- thyroid carcinoma consecutive cases
- clinical significance thyroid carcinomas